Welcome Novartis Poland!
New year, new plans, new partners. Recently another global company, Novartis Poland, has signed an agreement of cooperation within the Warsaw Health Innovation Hub. It is already 17th company that has joined our initiative.
The signing ceremony took place at the Medical Research Agency with the participation of the President of the Novartis Group in Poland, Michał Bichta.
- At Novartis we believe in the power of science and cooperation to create a new and better reality. It is a great privilege for us to join the Warsaw Health Innovation Hub to jointly propose innovative projects to improve patients' lives and health. We are proud that Novartis' global experience and scientific commitment, supported by the WHIH platform, will contribute to the creation of solutions responding to the urgent needs of the Polish health care system," said Michal Bichta, President of the Novartis Group in Poland
- We want the health care system to provide the most precise protection of patients' needs. Personalized medicine and rapidly developing digital technologies are becoming crucial in this respect. I am glad that Novartis within WHIH will be a part of creating innovative solutions in Polish health care. This is an essential direction for achieving better treatment outcomes for patients and modern health policy. - emphasizes Marta Wielondek, CEO of Novartis Oncology in Poland
- We are happy that another global company is taking part in the Warsaw Health Innovation Hub. We are even more satisfied that the experience of companies like Novartis Poland will allow us to jointly engage in the implementation of innovative projects within WHIH. I believe that together we will be able to develop solutions that will develop, improve and modernize the health care system for the benefit of Polish patients. - emphasizes Radosław Sierpiński, MD, President of the Medical Research Agency.